Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury
暂无分享,去创建一个
K. Tsuneyama | M. Kudo | K. Harada | Satoko Nakamura | T. Senoh | K. Takaguchi | Midori Andō | K. Mizobuchi | A. Tsutsui | T. Nagano
[1] S. Kaçar,et al. Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.
[2] Joong-Won Park,et al. Clinical Characteristics of Patients with Cryptogenic Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Area , 2015, Liver Cancer.
[3] Y. Nakanuma,et al. Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury , 2015, Mediators of inflammation.
[4] S. M. de la Monte,et al. Potential Role of Phosphorylation as a Regulator of Aspartyl-(asparaginyl)-β-hydroxylase: Relevance to Infiltrative Spread of Human Hepatocellular Carcinoma , 2015, Liver Cancer.
[5] P. Scheuer,et al. Scheuer's Liver Biopsy Interpretation , 2015 .
[6] A. Czaja. Diagnosis and management of autoimmune hepatitis , 2015, BMJ.
[7] M. Gershwin,et al. Emperipolesis Mediated by CD8 T Cells Is a Characteristic Histopathologic Feature of Autoimmune Hepatitis , 2015, Clinical Reviews in Allergy & Immunology.
[8] Yoshiro Saito,et al. A detection algorithm for drug‐induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale , 2014, Pharmacoepidemiology and drug safety.
[9] C. V. van Nieuwkerk,et al. Auto immune hepatitis. , 2016, World journal of gastroenterology.
[10] R. Andrade,et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug‐induced liver injury , 2011, Hepatology.
[11] J. Talwalkar,et al. Drug‐induced autoimmune hepatitis: Clinical characteristics and prognosis , 2010, Hepatology.
[12] J. Lefkowitch. Comprar Scheuer's Liver Biopsy Interpretation (Searchable Full Text Online) | Jay H. Lefkowitch | 9780702034107 | Saunders , 2010 .
[13] Michael P Holt,et al. Drug-induced liver injury. , 2010, Handbook of experimental pharmacology.
[14] J. Uetrecht,et al. Immunoallergic Drug-Induced Liver Injury in Humans , 2009, Seminars in liver disease.
[15] D. Kleiner,et al. The Pathology of Drug-Induced Liver Injury , 2009, Seminars in liver disease.
[16] K. Tajiri,et al. Practical guidelines for diagnosis and early management of drug-induced liver injury. , 2008, World journal of gastroenterology.
[17] I. Ng,et al. Molecular Pathogenesis of Hepatocellular Carcinoma , 2016, Liver Cancer.
[18] Y. Nakanuma,et al. Hepatic centrilobular zonal necrosis with positive antinuclear antibody: a unique subtype or early disease of autoimmune hepatitis? , 2007, Human pathology.
[19] 央 日高,et al. DDW-J2004薬物性肝障害ワークショップのスコアリングに関するvalidity study , 2007 .
[20] Paul B Watkins,et al. Drug‐induced liver injury: Summary of a single topic clinical research conference , 2006, Hepatology.
[21] E. Penner,et al. Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation , 2006, Journal of Clinical Pathology.
[22] R. Priori,et al. Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis , 2005, Annals of the rheumatic diseases.
[23] J. Misdraji,et al. Autoimmune Hepatitis With Centrilobular Necrosis , 2004, The American journal of surgical pathology.
[24] M. Setti,et al. Atorvastatin as a trigger of autoimmune hepatitis. , 2004, Journal of hepatology.
[25] N. Kaplowitz,et al. Drug-Induced Liver Injury , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] N. Kaplowitz,et al. Immune-mediated drug-induced liver disease. , 2002, Clinics in liver disease.
[27] S. Thorgeirsson,et al. Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.
[28] P. Schirmacher,et al. Autoimmune hepatitis and overlap syndromes. , 2002, Clinics in liver disease.
[29] E. Elias,et al. Recurrence of autoimmune hepatitis after liver transplantation. , 1999, Transplantation.
[30] M. Kaplan,et al. A novel histological lesion in glucocorticoid-responsive chronic hepatitis. , 1997, Gastroenterology.
[31] H. Nagura,et al. In situ distribution of enolase isozymes in chronic liver disease. , 1989, The American journal of gastroenterology.
[32] S. Pocock,et al. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. , 1980, Gut.
[33] L. Elveback,et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. , 1972, Gastroenterology.